CRMD

CRMD EBITDA Growth

378.11%TTM

Period ending:

CRMD TTM EBITDA YoY %%
CRMD TTM EBITDA YoY %1301.34%-736.91%
2010-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CRMD ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 63 observations from Dec 31, 2010 to Jun 30, 2026.

Cormedix Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
378.1055%
1,104.0858%
981.7673%
337.2543%
196.1616%
134.2894%
58.9511%
-19.2335%
-47.6889%
-52.8419%
-53.2141%
-33.3252%
-16.8528%
-15.4801%
-2.7041%
-7.7625%
-22.7525%
-1.7114%
-8.6875%
-4.9778%
-3.3898%
-34.6062%
-31.0186%
-99.3781%
-35.2914%
0.5818%
22.9122%
66.3547%
52.9203%
39.6756%
18.8255%
-34.952%
-37.9586%
-26.9467%
-34.2508%
-31.7521%
-59.9635%
-66.0045%
-34.8097%
-33.3701%
-4.7147%
-15.2515%
29.5318%
34.3106%
21.3073%
29.6233%
-428.2456%
-500.502%
-446.7772%
-539.6627%
-45.94%
-57.0178%
8.4245%
47.0071%
53.609%
89.0903%
81.6169%
72.0593%
69.0121%
-147.3335%
-149.7228%
-150.1499%
-286.0263%

Compare ebitda growth

All CRMD financial metrics · CRMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.